Drug Profile
G120K PEG
Alternative Names: G120K-PEGLatest Information Update: 06 Jul 1999
Price :
$50
*
At a glance
- Originator Sensus Drug Development Corporation
- Class Antihormones
- Mechanism of Action Somatotropin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic nephropathies
Most Recent Events
- 06 Jul 1999 Discontinued-Preclinical for Diabetic nephropathies in USA (Unknown route)
- 31 Mar 1999 Preclinical development for Diabetic nephropathies in USA (Unknown route)